神州细胞向特定对象发行股票申请获证监会同意注册批复

Core Viewpoint - The company, Beijing Shenzhou Cell Biotechnology Group Co., Ltd., has received approval from the China Securities Regulatory Commission for its application to issue stocks to specific investors [1] Group 1 - The approval is documented in the official notice numbered 2971, indicating the regulatory endorsement for the company's stock issuance [1]